✨ Your Portfolio is fetched and updated from zerodha.
Micro Chemicals

Eiko Lifesciences Ltd.

EIKO

Market Cap
₹87 Cr.
P/E
49.73

Eiko Lifesciences Ltd.

  • Eiko Lifesciences
  • Sunil Healthcare
  • Archit Organosys
FAQs on Eiko Lifesciences Ltd. Shareprice

Eiko Lifesciences has given better returns compared to its competitors.
Eiko Lifesciences has grown at ~22.04% over the last 1yrs while peers have grown at a median rate of 4.49%

Eiko Lifesciences is not expensive.
Latest PE of Eiko Lifesciences is 49.73, while 3 year average PE is 76.06.
Also latest EV/EBITDA of Eiko Lifesciences is 28.25 while 3yr average is 47.63.

View FAQ's On Business
Growth Table
  • Eiko Lifesciences Ltd.
  • Sunil Healthcare
  • Archit Organosys
Balance Sheet
  • Eiko Lifesciences Ltd.
  • Sunil Healthcare
  • Archit Organosys
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Eiko Lifesciences Ltd.
  • Sunil Healthcare
  • Archit Organosys
Cash Flow
  • Eiko Lifesciences Ltd.
  • Sunil Healthcare
  • Archit Organosys
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Eiko Lifesciences Ltd.
  • Sunil Healthcare
  • Archit Organosys
Quarterly Results
  • Eiko Lifesciences Ltd.
  • Sunil Healthcare
  • Archit Organosys
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF
FAQs on Eiko Lifesciences Ltd. Financials

Balance sheet of Eiko Lifesciences is strong.
But short term working capital might become an issue for this company.

Yes, The net debt of Eiko Lifesciences is increasing.
Latest net debt of Eiko Lifesciences is -₹9.02 Crs as of Mar-25.
This is greater than Mar-24 when it was -₹26.68 Crs.

The profit is oscillating.
The profit of Eiko Lifesciences is ₹2.18 Crs for TTM, ₹0.75 Crs for Mar 2024 and ₹0.77 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Eiko Lifesciences latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech